Metastatic hormone-sensitive prostate cancer Clinical Trials
Conditions / Metastatic hormone-sensitive prostate cancer
Delta Trials indexes 2 clinical trials for Metastatic hormone-sensitive prostate cancer in its publicly accessible dataset. Of these, 2 enrolling participants at this time and 0 trials have reached completion. This research takes place spanning 59 research sites around the world. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity has changed over time.
Trial Status
2
Total Trials
2
Recruiting
0
Completed
0
Other Active
0
Terminated since 2020
59
Study Locations
Browse by location (59 total)
- Bethesda, United States 1 trialAll trials in Bethesda, United States
- New Haven, United States 1 trialAll trials in New Haven, United States
- Hamburg, Germany 1 trialAll trials in Hamburg, Germany
- Kielce, Poland 1 trialAll trials in Kielce, Poland
- Barcelona, Spain 1 trialAll trials in Barcelona, Spain
- Marseille, France 1 trialAll trials in Marseille, France
- Quint-fonsegrives, France 1 trialAll trials in Quint-fonsegrives, France
- Badajoz, Spain 1 trialAll trials in Badajoz, Spain
- Halifax, Canada 1 trialAll trials in Halifax, Canada
- Multiple Locations, South Korea 1 trialAll trials in Multiple Locations, South Korea
- Montréal, Canada 1 trialAll trials in Montréal, Canada
- Hoofddorp, Netherlands 1 trialAll trials in Hoofddorp, Netherlands
- Asti, Italy 1 trialAll trials in Asti, Italy
- Nice, France 1 trialAll trials in Nice, France
- Santa Monica, United States 1 trialAll trials in Santa Monica, United States
- Schiedam, Netherlands 1 trialAll trials in Schiedam, Netherlands
- Omaha, United States 1 trialAll trials in Omaha, United States
- Myrtle Beach, United States 1 trialAll trials in Myrtle Beach, United States
- Norfolk, United States 1 trialAll trials in Norfolk, United States
- Lübeck, Germany 1 trialAll trials in Lübeck, Germany